Kanagawa, Japan

Tomoya Yukawa

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 11.8

ph-index = 2

Forward Citations = 11(Granted Patents)


Location History:

  • Osaka, JP (2014)
  • Kanagawa, JP (2014 - 2018)
  • Fujisawa, JP (2017 - 2018)

Company Filing History:


Years Active: 2014-2018

Loading Chart...
Loading Chart...
10 patents (USPTO):

Title: Innovator Spotlight: Tomoya Yukawa - Pioneering Advances in Heterocyclic Compounds

Introduction: Tomoya Yukawa, an accomplished inventor based in Kanagawa, Japan, has made significant strides in the world of pharmaceutical innovation. With a total of 10 patents to his name, his work is instrumental in advancing drug development and therapeutic applications.

Latest Patents: Among his latest contributions to the field are patents related to heterocyclic compounds and their effects as retinoid-related orphan receptor (ROR) gamma-T inhibitors. These compounds, represented by specific chemical formulas, exhibit inhibitory actions important for various medical applications. The details of these compounds and their potential use underscore the innovative nature of Yukawa's research.

Career Highlights: Yukawa's career is marked by his tenure at Takeda Pharmaceutical Company Limited, a leading global pharmaceutical firm known for its commitment to innovation and research. His work aligns with the company's mission to improve health outcomes through advanced therapies.

Collaborations: Throughout his career, Yukawa has collaborated with notable colleagues, including Satoshi Yamamoto and Junya Shirai. These partnerships have fostered an environment of innovation and knowledge sharing, contributing to the successful development of new pharmaceutical solutions.

Conclusion: Tomoya Yukawa exemplifies the spirit of innovation in the pharmaceutical industry. His dedication to creating impactful compounds and his collaborative efforts underscore the importance of breaking new ground in drug development. As he continues to contribute to Takeda Pharmaceutical Company Limited, the implications of his work promise to lead to significant advancements in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…